ArticleJournal of nanobiotechnology2022

Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity.

Man Kyu Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.